New drug trial seeks to regrow hair in men with baldness
NCT ID NCT07076706
Summary
This study tested an investigational drug called CG2001 to see if it could help regrow hair in men with male pattern baldness. It involved 110 Chinese men who applied the treatment or a placebo for 24 weeks. The main goal was to see if it increased hair count and thickness, and to find the right dose for future, larger studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA (AGA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tongren Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, China
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
-
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
-
Huashan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China
-
Jiangxi Provincial Dermatology Hospital
Nanchang, Jiangxi, China
-
Peking University People's Hospital
Beijing, China
-
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
-
Xiangya Hospital of Central South University
Changsha, Hunan, China
Conditions
Explore the condition pages connected to this study.